Sorafenib Activity and Disposition in Liver Cancer Does Not Depend on Organic Cation Transporter 1

Mingqing Chen1, Claudia Neul2,3, Elke Schaeffeler2,3,4

  • 1Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.

Insights

Organic cation transporter 1 (OCT1) does not transport sorafenib, a drug used for advanced hepatocellular carcinoma (HCC). This study indicates OCT1 is not a valid biomarker for predicting sorafenib response in HCC patients.

Area of Science:

  • Pharmacology
  • Oncology
  • Molecular Biology

Background:

  • Systemic therapy for advanced hepatocellular carcinoma (HCC) using sorafenib exhibits significant interindividual pharmacokinetic variability and unpredictable side effects.
  • Organic cation transporter 1 (OCT1), encoded by the SLC22A1 gene, has been suggested as a potential clinical biomarker for predicting HCC treatment response.

Purpose of the Study:

  • To investigate the role of OCT1 in the cellular uptake and transport of sorafenib.
  • To determine if OCT1 functions as a transporter for sorafenib and assess its validity as a biomarker for sorafenib response in HCC.

Main Methods:

  • Utilized Xenopus laevis oocytes and mammalian cell lines overexpressing functional OCT1 protein to assess sorafenib transport.
  • Analyzed sorafenib accumulation in liver cancer cell lines with varying OCT1 expression levels.
  • Examined sorafenib pharmacokinetics in mice with different OCT1 genotypes.
  • Investigated SLC22A1 mRNA expression and its correlation with DNA methylation in The Cancer Genome Atlas (TCGA) HCC cohort.

Main Results:

  • Overexpression of OCT1 in oocytes and cell lines did not facilitate sorafenib transport.
  • Sorafenib accumulated in liver cancer cell lines irrespective of OCT1 mRNA and protein levels.
  • Sorafenib pharmacokinetics in mice were independent of OCT1 genotype.
  • SLC22A1 mRNA expression was significantly reduced by DNA methylation in HCC samples from the TCGA.

Conclusions:

  • Cellular uptake of sorafenib is independent of OCT1.
  • OCT1 is not a valid biomarker for predicting sorafenib response or guiding treatment decisions in advanced HCC.

Related Concept Videos

Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
137.3K
Secondary Active Transport01:32

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
9.4K
Primary Active Transport01:47

Primary Active Transport

In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction...
196.7K
Primary Active Transport01:29

Primary Active Transport

In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction they would...
13.7K
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
2.0K
Facilitated Transport01:19

Facilitated Transport

The chemical and physical properties of plasma membranes cause them to be selectively permeable. Since plasma membranes have both hydrophobic and hydrophilic regions, substances need to be able to transverse both regions. The hydrophobic area of membranes repels substances such as charged ions. Therefore, such substances need special membrane proteins to cross a membrane successfully. In  facilitated transport, also known as facilitated diffusion, molecules and ions travel across a...
146.4K